NKTR-214 + nivolumab in first-line advanced/metastatic urothelial carcinoma (mUC): Updated results from PIVOT-02.
暂无分享,去创建一个
M. Fishman | Jianjun Gao | A. Balar | A. Siefker-Radtke | J. Zalevsky | M. Tagliaferri | G. Grignani | M. Bilen | A. Diab | A. Hannah | U. Hoch | A. Rizwan | Erin E. Karski